Full details of the Pharmacy Quality Scheme (PQS) 2026/27 are now available on our PQS hub page following the announcement on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2026/27 on Friday (29th May 2026) and a Drug Tariff Update which was published today (2nd June 2026). View the PQS 2026/27 hub page [...]
The post New Pharmacy Quality Scheme for 2026/27 announced appeared first on Community Pharmacy England.
The list of price concessions granted for May 2026 currently includes 219 lines. With a few more lines still being discussed, this already surpasses the number of price concessions granted in the previous two record-breaking months. Third month of record drug price concessions | Chemist+Druggist The continuation of this concerning trend is putting more pressure [...]
The post Third month of record price concessions appeared first on Community Pharmacy England.
Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 June 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Semaglutide 1.5mg tablets Rybelsus® 1.5mg tablets (Novo Nordisk Ltd) 30 tablet [...]
The post 3 products re-classified as special containers from June 2026 appeared first on Community Pharmacy England.
Announcement Summary Funding to increase by 10.3% (£340m) in 2026/27 to £3.636 billion Government commits to working jointly on programme of reform, which will be critically important to set the future strategy for the sector Margin write-off up to end of 2025/26, and funding uplift includes £200 million to be added to the annual margin [...]
The post CPE secures 10% funding rise, but pushes for reform appeared first on Community Pharmacy England.
MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) Drug alert number: EL(26)A/25 Date issued: 28 May 2026 Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site. DMRC reference number: DMRC-39617807 Company name: Crescent Pharma [...]
The post MHRA Class 2 Medicines Recall: Ramipril 2.5mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.
Recent Comments